SHPMF / Shanghai Pharmaceuticals Holding Co., Ltd - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Shanghai Pharmaceuticals Holding Co., Ltd
US ˙ OTCPK ˙ CNE1000012B3

Mga Batayang Estadistika
CIK 1570300
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Shanghai Pharmaceuticals Holding Co., Ltd
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
November 22, 2019 EX-99.(E)

Certification under Rule 466

Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6Pos (Knorr-Bremse AG 333-227925) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and time of eff

November 22, 2019 EX-99.(A)

JPMorgan Chase Bank, N.A. American Depositary Receipt American Depositary Shares Representing Ordinary Shares of Shanghai Pharmaceuticals Holding Co Ltd (Incorporated under the laws of China)

Number Each American Depositary Share represents Five Shares JPMorgan Chase Bank, N.

November 22, 2019 F-6EF

DMLRY / Daimler AG F-6EF - -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Shanghai Pharmaceuticals Holding Co Ltd (Exact name of Issuer of deposited securities as specified in its charter) China (Jurisdiction of Incorporation or organization of Issuer) JPMorgan Chase Bank, N.A.

November 22, 2019 EX-99.(D)

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 October 15, 2019

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 October 15, 2019 JPMorgan Chase Bank, N.

February 21, 2013 F-6EF

- FORM F-6

As filed with the Securities and Exchange Commission on February 21, 2013 Registration No.

February 21, 2013 EX-4

Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730

Writer’s Direct Dial EXHIBIT 4 Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.

February 21, 2013 EX-1

THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY ‘H’ SHARES OF SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (INCORPORATED UNDER THE LAWS OF CHINA)

AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents Five (5) Shares) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY ‘H’ SHARES OF SHANGHAI PHARMACEUTICALS HOLDING CO.

Other Listings
HK:2607 HK$ 12.07
DE:S1R € 1.29
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista